Impact factor: 10.377
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. ARD is the official journal of EULAR.
Impact Factor: 10.377 (Number 1 journal in the Rheumatology category)
Faster submission process
We know that authors can find the manuscript submission process time-consuming, so we are pleased to report that we have implemented a streamlined submission process for original research articles. By asking fewer questions at initial submission we hope to minimise the time that authors spend uploading their manuscripts and responding to post-submission queries, resulting in a faster time to first decision.
Seeking new Editor-in-Chief
BMJ and EULAR are searching for a new Editor-in-Chief for Annals of the Rheumatic Diseases. The closing date for applications is 31st March 2016. It is envisaged that the successful candidate will work alongside the current Editor-in-Chief for a period of time, and officially take up the post in April 2017.
ARD publishes summaries for patients and non-clinicians that clearly explain the findings and treatment implications arising from key research papers published in the journal. They are checked for accuracy and readability by the ARD editors and PARE, and are free to access.
The second edition of the EULAR Textbook on Rheumatic Diseases and the EULAR Textbook on Systemic Sclerosis are available to order online now.